Graft coronary artery disease in murine cardiac allografts: proposal to meet the need for standardized assessment

J Heart Lung Transplant. 2005 Mar;24(3):316-22. doi: 10.1016/j.healun.2003.12.011.

Abstract

Background: Inconsistency exists in assessing the severity of graft coronary artery disease (GCAD) in studies that use mouse models. The central issue associated with this inconsistency is the lack of a standardized approach for assessing mouse GCAD.

Methods: We propose a new histologic definition of GCAD based on 3 successive stages (endotheliitis, premature lesion, and mature lesion) that mark the progression of this condition. In addition to these qualitative measures of GCAD, we propose including 2 additional morphometric parameters (percentage of luminal narrowing and intima-to-media ratio) and a measure of distribution (percentage of affected vessels) in the routine quantification of GCAD.

Results: We introduce 2 new mouse models of GCAD as examples that satisfy these criteria.

Conclusion: The proposed assessment criteria may simplify data collection and interpretation of results in various models of GCAD.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • Coronary Disease / pathology*
  • Disease Models, Animal
  • Disease Progression
  • Graft Occlusion, Vascular / pathology*
  • Heart Transplantation / adverse effects*
  • Immunohistochemistry
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mice, Inbred Strains
  • Transplantation, Homologous